- Home
- ARVN vs SCSC Comparison
ARVN vs SCSC Comparison
Compare ARVN & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | SCSC |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 769.9M |
| IPO Year | 2018 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ARVN | SCSC |
|---|---|---|
| Price | $10.13 | $36.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 1 |
| Target Price | $15.35 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 670.7K | 163.2K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ 1.63 |
| Revenue | $262,600,000.00 | ★ $3,846,260,000.00 |
| Revenue This Year | N/A | $2.60 |
| Revenue Next Year | N/A | $4.01 |
| P/E Ratio | ★ N/A | $22.57 |
| Revenue Growth | N/A | ★ 7.79 |
| 52 Week Low | $5.90 | $28.76 |
| 52 Week High | $14.22 | $46.25 |
Technical Indicators
Market Signals| Indicator | ARVN | SCSC |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 46.90 |
| Support Level | $9.02 | $35.57 |
| Resistance Level | $10.18 | $42.84 |
| Average True Range (ATR) | 0.67 | 1.10 |
| MACD | -0.22 | 0.22 |
| Stochastic Oscillator | 4.18 | 65.14 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.